Literature DB >> 15765302

Sonographic characterisation of hepatocellular carcinoma at time of diagnosis.

A Ignee1, D Weiper, G Schuessler, G Teuber, D Faust, C F Dietrich.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant liver tumour with a high prevalence world-wide. For screening procedures conventional transabdominal B-mode ultrasound and AFP determination are commonly used. We investigated 100 consecutive patients with histologically proven hepatocellular carcinoma in order to evaluate sonographic characteristics in unselected patients and to compare native and contrast-enhanced ultrasonographic techniques. PATIENTS AND METHODS: We investigated 100 consecutive patients with hepatocellular carcinoma at time of diagnosis with respect to echogenicity, patterns of vascularity, and portal/hepatic vein thrombosis. In addition to B-mode and native power Doppler sonography, contrast-enhanced power Doppler sonography with SHU 508A was used in 65 patients.
RESULTS: The ultrasound appearance with conventional B-mode of hepatocellular carcinoma was hypoechoic in 48 % of the cases, isoechoic in 9 %, hyperechoic in 19 %, and in 25 % a mixture between hyper- and hypoechoic appearance was found compared to the surrounding liver tissue. Contrast-enhanced power Doppler sonography with SHU 508A changed the pattern of tumour vascularity in 27 % of patients into hypervascular, mainly in small lesions. DISCUSSION: At the time of diagnosis, the most commonly observed finding in hepatocellular carcinoma is that they appear hypervascular, independent of their size. The use of ultrasound contrast media should be considered to achieve characterisation of liver nodules in cirrhotic livers because they can improve the evaluation of tumour vascularity. Hypovascular HCC are found in about 10 % even after the administration of a contrast agent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765302     DOI: 10.1055/s-2004-813815

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  8 in total

1.  Dynamic changes in ultrasound characteristics of nodules in cirrhotic liver and their implications in surveillance for malignancy.

Authors:  Size Wu; Rong Tu; Guangqing Liu; Yusen Shi
Journal:  J Med Ultrason (2001)       Date:  2013-09-03       Impact factor: 1.314

Review 2.  Functional imaging of hepatocellular carcinoma.

Authors:  Tim Ch Hoogenboom; Mark Thursz; Eric O Aboagye; Rohini Sharma
Journal:  Hepat Oncol       Date:  2016-03-29

3.  Relative Elastic Modulus Imaging Using Sector Ultrasound Data for Abdominal Applications: An Evaluation of Strategies and Feasibility.

Authors:  Bo Peng; Yu Wang; Wenjun Yang; Tomy Varghese; Jingfeng Jiang
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2016-07-09       Impact factor: 2.725

4.  Surveillance of hepatocellular carcinoma by medical imaging.

Authors:  Christoph F Dietrich; Andreas Teufel; Claude B Sirlin; Yi Dong
Journal:  Quant Imaging Med Surg       Date:  2019-11

Review 5.  Fortuitously discovered liver lesions.

Authors:  Christoph F Dietrich; Malay Sharma; Robert N Gibson; Dagmar Schreiber-Dietrich; Christian Jenssen
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 6.  Ultrasound contrast agents.

Authors:  Andre Ignee; Nathan S S Atkinson; Gudrun Schuessler; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2016 Nov-Dec       Impact factor: 5.628

7.  Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective.

Authors:  Claudio Tana; Cosima Schiavone; Andrea Ticinesi; Fulvio Lauretani; Antonio Nouvenne; Christoph Frank Dietrich; Tiziana Meschi
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

8.  Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience.

Authors:  Adriana Ciocalteu; Sevastita Iordache; Sergiu Marian Cazacu; Cristiana Marinela Urhut; Sarmis Marian Sandulescu; Ana-Maria Ciurea; Adrian Saftoiu; Larisa Daniela Sandulescu
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.